LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 4589
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

HEMATOLOGY SECTION - ORIGINAL ARTICLE

Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes

Varma Neelam, Varma Subhash

Year : 2008| Volume: 51| Issue : 1 | Page no: 97-101

   This article has been cited by
 
1 The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia
Harpreet Virk, Sonia Rana, Alpeshkumar B. Kapadia, Sreejesh Sreedharanunni, Nabhajit Mallik, Narender Kumar, Prashant Sharma, Shano Naseem, Man Updesh Singh Sachdeva, Jasmina Ahluwalia, Reena Das, Neelam Varma, Pankaj Malhotra
International Journal of Laboratory Hematology. 2020; 42(6)
[Pubmed]  [Google Scholar] [DOI]
2 Prevalence of Chromosome 7 Abnormalities in Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single Center Study and Brief Literature Review
Ruchi Gupta,Shivangi Harankhedkar,Khaliqur Rahman,Manish K. Singh,Dinesh Chandra,Navkirti Mittal,Anshul Gupta,Soniya Nityanand
Indian Journal of Hematology and Blood Transfusion. 2018; 34(4): 602
[Pubmed]  [Google Scholar] [DOI]
3 Analysis of the presence of FLT3 gene mutation and association with prognostic factors in adult and pediatric acute leukemia patients
Graciele Burnatt,Marley Aparecida Licínio,Pâmela Cristina Gaspar,Arthur Schveitzer Ferreira,Manoela Lira Reis,Ana Carolina Rabello de Moraes,Thaís Cristine Marques Sincero,Maria Cláudia Santos-Silva
Brazilian Journal of Pharmaceutical Sciences. 2017; 53(2)
[Pubmed]  [Google Scholar] [DOI]
4 A STUDY OF THE PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE LEVELS IN MYELODYSPLASTIC SYNDROME
Praveen Malayath
Journal of Evidence Based Medicine and Healthcare. 2017; 4(95): 5930
[Pubmed]  [Google Scholar] [DOI]
5 Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report
KUI SONG,XIAOJUN XU,MIN LI
Oncology Letters. 2015; 10(1): 422
[Pubmed]  [Google Scholar] [DOI]
6 Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients
R. Chaubey,S. Sazawal,M. Mahapatra,S. Chhikara,R. Saxena
International Journal of Laboratory Hematology. 2015; 37(2): 265
[Pubmed]  [Google Scholar] [DOI]
7 Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
Pellagatti, A., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M.G., Jädersten, M., Boultwood, J.
Leukemia. 2010; 24(4): 756-764
[Pubmed]  [Google Scholar] [DOI]
8 Myelodysplasic symdrome: Molecular and laboratorial aspects and the 2008 who classification | [Síndromes mielodisplásicas: Aspectos moleculares, laboratoriais e a classificação OMS 2008]
Moraes, A.C.R., Licínio, M.A., Pagnussat, L., del Moral, J.A.G., Santos-Silva, M.C.
Revista Brasileira de Hematologia e Hemoterapia. 2009; 31(6): 463-470
[Pubmed]  [Google Scholar]

 

Read this article